Gemcitabine and liposomal doxorubicin in biliary and hepatic carcinoma (HCC) chemotherapy: preliminary results and review of the literature.
about
Diphenyl difluoroketone: a potent chemotherapy candidate for human hepatocellular carcinomaThe cancer stem cell paradigm: a new understanding of tumor development and treatment.Systemic chemotherapy for hepatocellular carcinoma in non-cirrhotic liver: a retrospective study.Down-regulation of RhoE is associated with progression and poor prognosis in hepatocellular carcinoma.Short-term imaging response after drug-eluting embolic trans-arterial chemoembolization delivered with the Surefire Infusion System® for the treatment of hepatocellular carcinoma.
P2860
Gemcitabine and liposomal doxorubicin in biliary and hepatic carcinoma (HCC) chemotherapy: preliminary results and review of the literature.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Gemcitabine and liposomal doxo ...... and review of the literature.
@ast
Gemcitabine and liposomal doxo ...... and review of the literature.
@en
type
label
Gemcitabine and liposomal doxo ...... and review of the literature.
@ast
Gemcitabine and liposomal doxo ...... and review of the literature.
@en
prefLabel
Gemcitabine and liposomal doxo ...... and review of the literature.
@ast
Gemcitabine and liposomal doxo ...... and review of the literature.
@en
P2093
P356
P1433
P1476
Gemcitabine and liposomal doxo ...... s and review of the literature
@en
P2093
D Pastorelli
F Farinati
F Marchese
F Zustovich
M Mattiazzi
P304
P356
10.1093/ANNONC/MDJ972
P478
17 Suppl 5
P577
2006-05-01T00:00:00Z